Practice Areas
Blockchain, Cryptocurrency, and Digital Assets
Corporate
Corporate Finance
Corporate Governance
Environmental, Social & Governance (ESG)
Mergers & Acquisitions
Private Equity
Special Purpose Acquisition Companies (SPACs)
Admissions
U.S. District Court, Southern District of New York
Connecticut
New York
Education
Fordham University School of Law - J.D., 1991
Georgetown University - A.B., 1988, cum laude
|
Profile
William Mills is the New York Office Managing Partner and a member of the management committee. He advises public and private companies, boards of directors and financial advisers on complex, high-value corporate transactions and strategic matters.
His practice spans the full spectrum of public and private M&A and corporate activity, including acquisitions, divestitures, spin-offs, leveraged buyouts and contested situations such as shareholder activism and proxy contests. Bill regularly counsels boards and senior management on corporate governance, fiduciary duties and disclosure, providing clear, commercially focused guidance in high-stakes and time-sensitive environments.
Bill also advises on complex and distressed situations, including transactions involving financially challenged businesses, restructurings and special situations, bringing a pragmatic and solutions-oriented approach to executing difficult deals.
Recognition
- IFLR1000 – Leading M&A Lawyer (2012-2024)
- Legal 500 – Key Individual (2013 - 2023)
- Lawdragon – 500 Leading Dealmakers in America (2012-2026)
Experience
- Advising WillisTowersWatson on its acquisition of Flowstone Partners.
- Advising AlTi Global on its strategic investment from Allianz X and Constellation Wealth Capital.
- Advising AngioDynamics on its acquisitions of RadiaDyne, Navilyst Medical, Microsulis Medical, Vortex Medical, and Clinical Devices and the sale of its NAMIC® fluid management portfolio to Medline Industries and the sale of its Dialysis portfolio and BioSentry product line to Merit Medical Systems.
- Advising Forbes Media on its sale to a consortium of international investors and its proposed business combination with Magnum Opus Acquisition and strategic investment from Binance.
- Advising Corindus Vascular Robotics on its US$1.1bn acquisition by Siemens Healthineers.
- Advising Willis Towers Watson on its acquisitions of Acclaris, Extend Health, and Liazon Corporation, and the sale of its reinsurance brokerage to JLT.
- Advising Genpact on its acquisitions of Barkawai Management Consultants, OnSource, and TandemSeven.
- Advising Inteva Products on the sale of its roof systems business to CIE Automotive.
- Advising Salix Pharmaceuticals on its US$15.6bn acquisition by Valeant Pharmaceuticals International.
- Advising Pfizer on its acquisitions of Embrex, King Pharmaceuticals, Vicuron Pharmaceuticals, Warner-Lambert and Wyeth, and in the respective sales of its Capsugel business to KKR its consumer health care division for $16 billion to Johnson & Johnson.
- Advising Élan on its $3.25 billion sale of Tysabri rights to Biogen Idec.
- Advising the United States Department of the Treasury on the management of its $250 billion TARP Capital Purchase Program.
- Advising Seacoast Banking Corp. on its acquisitions of Floridian Financial Group and GulfShore Bancshares and successful defense against an activist campaign.
- Advising Republic Bancorp on its merger with Citizens Banking Corporation.
- Credit Suisse on its acquisitions of Select Portfolio Servicing and Lime Financial.
- Advising Bear Stearns Companies Inc. in its acquisition of United Companies Financial and $1.2 billion merger with JPMorgan Chase & Co.
- Advising the Special Committee of the Board of Directors of Landry’s Restaurants in the acquisition of Landry’s by Tilman J. Fertitta.
- Advising Medifast on corporate governance matters, including its successful defense of campaigns by Engaged Capital.
- Advising Goldman Sachs, JP Morgan, Barclays and Centerviewas financial advisors on certain mergers and acquisition matters.
|
